12/20
01:30 am
srts
Sensus Healthcare (NASDAQ:SRTS) was upgraded by analysts at
Wall Street
Low
Report
Sensus Healthcare (NASDAQ:SRTS) was upgraded by analysts at
Wall Street
11/14
08:17 am
srts
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer [Yahoo! Finance]
Low
Report
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer [Yahoo! Finance]
11/14
08:00 am
srts
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Medium
Report
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
11/12
08:00 am
srts
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Medium
Report
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
11/9
07:03 pm
srts
US$7.50: That's What Analysts Think Sensus Healthcare, Inc. (NASDAQ:SRTS) Is Worth After Its Latest Results [Yahoo! Finance]
Medium
Report
US$7.50: That's What Analysts Think Sensus Healthcare, Inc. (NASDAQ:SRTS) Is Worth After Its Latest Results [Yahoo! Finance]
11/6
09:49 pm
srts
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
04:05 pm
srts
Sensus Healthcare Reports Third Quarter 2025 Financial Results
High
Report
Sensus Healthcare Reports Third Quarter 2025 Financial Results
11/6
08:00 am
srts
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
Medium
Report
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
11/4
08:00 am
srts
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
High
Report
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
10/31
08:00 am
srts
Sensus Healthcare Announces the Passing of Director Bill McCall
Low
Report
Sensus Healthcare Announces the Passing of Director Bill McCall
10/24
05:33 am
srts
Sensus Healthcare (NASDAQ:SRTS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Sensus Healthcare (NASDAQ:SRTS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
10/23
08:29 pm
srts
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
Medium
Report
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
10/23
08:00 am
srts
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
Medium
Report
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
10/16
08:22 pm
srts
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
Medium
Report
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
10/9
12:58 pm
srts
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
Low
Report
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
9/29
08:25 pm
srts
Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]
Low
Report
Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]
9/28
10:00 am
srts
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS